CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.87
1.05 (1.79%)
At close: Aug 15, 2025, 1:20 PM
CRISPR Therapeutics Revenue
CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending June 30, 2025, CRISPR Therapeutics generated $892K in revenue.
Revenue (ttm)
35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
89.06K
Employees
393
Market Cap
5.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|